• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis?

作者信息

Hoenigl Martin, Prattes Juergen

机构信息

Division of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria; BioTechMed, Graz, Austria.

Division of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.

出版信息

Lancet Respir Med. 2024 Mar;12(3):183-185. doi: 10.1016/S2213-2600(23)00435-6. Epub 2024 Jan 4.

DOI:10.1016/S2213-2600(23)00435-6
PMID:38185136
Abstract
摘要

相似文献

1
Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis?2019冠状病毒病相关肺曲霉病的风险：是时候采取细致入微的抗真菌预防方法了吗？
Lancet Respir Med. 2024 Mar;12(3):183-185. doi: 10.1016/S2213-2600(23)00435-6. Epub 2024 Jan 4.
2
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.抗真菌预防治疗预防危重症 COVID-19 相关侵袭性肺曲霉病：一项观察性研究。
Crit Care. 2021 Sep 15;25(1):335. doi: 10.1186/s13054-021-03753-9.
3
Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.迈向新型冠状病毒肺炎相关肺曲霉病伏立康唑给药的个性化与综合管理
Crit Care. 2021 Apr 20;25(1):152. doi: 10.1186/s13054-021-03568-8.
4
[What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis].[侵袭性真菌病治疗的新进展……：新型冠状病毒肺炎相关肺曲霉病]
Anaesthesist. 2021 May;70(5):432-433. doi: 10.1007/s00101-021-00931-w. Epub 2021 Feb 26.
5
COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.COVID-19 相关的 ICU 患者肺曲霉病：抗真菌预防的影响。
Mycopathologia. 2024 Jan 13;189(1):3. doi: 10.1007/s11046-023-00809-y.
6
Assessing the entire landscape of antifungal immune response to COVID-19-associated pulmonary aspergillosis.评估针对新型冠状病毒肺炎相关肺曲霉病的抗真菌免疫反应全貌。
Lancet Microbe. 2024 Aug;5(8):100861. doi: 10.1016/S2666-5247(24)00076-4. Epub 2024 Apr 23.
7
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病：2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
8
Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all.机械通气患者中COVID-19相关肺曲霉病的抗真菌预防：一种解决方案并不适用于所有人。
Intensive Care Med. 2024 Aug;50(8):1375-1377. doi: 10.1007/s00134-024-07542-0. Epub 2024 Jul 9.
9
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.伊朗重症 COVID-19 肺炎住院患者的 COVID-19 相关肺曲霉病 (CAPA)。
Infection. 2023 Feb;51(1):223-230. doi: 10.1007/s15010-022-01907-7. Epub 2022 Sep 15.
10
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.应对 COVID-19 相关曲霉病的不确定性：与流感相关曲霉病的比较。
J Infect Dis. 2021 Nov 22;224(10):1631-1640. doi: 10.1093/infdis/jiab163.